Literature DB >> 21427573

Update on nonsurgical therapy for diabetic macular edema.

Andre J Witkin1, Gary C Brown.   

Abstract

PURPOSE OF REVIEW: Treatment for diabetic macular edema (DME) is continuously evolving. While focal laser photocoagulation remains the standard of care, a new wave of studies is emerging that shows benefit of adjunctive therapy for DME. RECENT
FINDINGS: With the advent of intravitreal corticosteroid and antivascular endothelial growth factor medications, new interest in the treatment of DME has been piqued, and a number of clinical trials have been designed to evaluate these therapies.
SUMMARY: The goal of this article is to briefly summarize recent data from these trials, in order to aid the clinician in evaluating the most appropriate and up-to-date nonsurgical management options in treating diabetic macular edema. The key points are to summarize the most recent peer-reviewed literature regarding therapy for diabetic macular edema. Particular attention is paid to focal laser, corticosteroid, and anti-VEGF therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21427573     DOI: 10.1097/ICU.0b013e3283459724

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  14 in total

1.  Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.

Authors:  Xiaoban Xin; Murilo Rodrigues; Mahaa Umapathi; Fabiana Kashiwabuchi; Tao Ma; Savalan Babapoor-Farrokhran; Shuang Wang; Jiadi Hu; Imran Bhutto; Derek S Welsbie; Elia J Duh; James T Handa; Charles G Eberhart; Gerard Lutty; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

2.  Persistent suppression of ocular neovascularization with intravitreal administration of AAVrh.10 coding for bevacizumab.

Authors:  Yanxiong Mao; Szilard Kiss; Julie L Boyer; Neil R Hackett; Jianping Qiu; Andrew Carbone; Jason G Mezey; Stephen M Kaminsky; Donald J D'Amico; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2011-10-27       Impact factor: 5.695

3.  Prognostic factors of short-term outcomes of intravitreal ranibizumab in diabetic macular edema.

Authors:  I-An Lai; Wei-Cherng Hsu; Chung-May Yang; Yi-Ting Hsieh
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

Review 4.  Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases.

Authors:  Mayur Choudhary; Goldis Malek
Journal:  J Biomol Screen       Date:  2016-07-28

5.  Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo.

Authors:  Qingguo Xu; Nicholas J Boylan; Jung Soo Suk; Ying-Ying Wang; Elizabeth A Nance; Jeh-Chang Yang; Peter J McDonnell; Richard A Cone; Elia J Duh; Justin Hanes
Journal:  J Control Release       Date:  2013-01-28       Impact factor: 9.776

6.  Diabetic macular edema: therapeutic options.

Authors:  Amol D Kulkarni; Michael S Ip
Journal:  Diabetes Ther       Date:  2012-03-06       Impact factor: 2.945

7.  AMPK-NF-κB axis in the photoreceptor disorder during retinal inflammation.

Authors:  Mamoru Kamoshita; Yoko Ozawa; Shunsuke Kubota; Seiji Miyake; Chiduru Tsuda; Norihiro Nagai; Kenya Yuki; Shigeto Shimmura; Kazuo Umezawa; Kazuo Tsubota
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

Review 8.  Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.

Authors:  Uday B Kompella; Rachel R Hartman; Madhoosudan A Patil
Journal:  Prog Retin Eye Res       Date:  2020-09-04       Impact factor: 21.198

Review 9.  The evolving treatment options for diabetic macular edema.

Authors:  Atul Jain; Neeta Varshney; Colin Smith
Journal:  Int J Inflam       Date:  2013-09-09

10.  Intraocular soluble intracellular adhesion molecule-1 correlates with subretinal fluid height of diabetic macular edema.

Authors:  Dan Zhu; He Zhu; Chunyan Wang; Dayong Yang
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.